Is Fresenius Medical Care AG & Co. (FMS) Stock a Smart Investment Tuesday?

Fresenius Medical Care AG & Co. (FMS) stock has fallen -19.07% over the last 12 months, and the average rating from Wall Street analysts is a Sell. InvestorsObserver’s proprietary ranking system, gives FMS stock a score of 66 out of a possible 100.

That rank is primarily influenced by a long-term technical score of 71. FMS's rank also includes a short-term technical score of 70. The fundamental score for FMS is 56. In addition to the average rating from Wall Street analysts, FMS stock has a mean target price of $37.08. This means analysts expect the stock to increase 16.62% over the next 12 months.

FMS has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on FMS!

See Full FMS Report

What's Happening with FMS Stock Today

Fresenius Medical Care AG & Co. (FMS) stock is lower by -2.27% while the S&P 500 has fallen -1.84% as of 11:11 AM on Tuesday, Apr 26. FMS has fallen -$0.74 from the previous closing price of $32.53 on volume of 125,480 shares. Over the past year the S&P 500 is higher by 0.70% while FMS has fallen -19.07%. FMS earned $1.77 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 17.95. Click Here to get the full Stock Report for Fresenius Medical Care AG & Co. stock.